Bold Capital
2 rounds tracked since 30 June 2025.
- Rounds
- 2
- Led
- 1
- Capital in these rounds
- $49M
Sectors
Countries
Rounds
- AqtualLeadcfDNA chromatin blood tests predicting therapy response, starting with rheumatoid arthritis $31MSeries B · 10 Jul
- GallantReady-to-use stem cell therapies for pets $18MSeries B · 30 Jun
No round matches these filters.